Skip to main content
AMWL
NYSE Trade & Services

Amwell Q2 Revenue Drops 27% but Cost Cuts Narrow Loss, Full-Year Outlook Raised

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$11.75
Mkt Cap
$174.102M
52W Low
$3.71
52W High
$13.45
52W Position info
217% above low
Off High info
13% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

AMWL has more than doubled off its 52-week low of $3.71.

Summary

Amwell reported Q2 2026 revenue of $52 million, down 27% year-over-year, but narrowed its net loss to $9.6 million through cost cuts. The company raised its full-year revenue and Adjusted EBITDA guidance and reiterated its goal of positive operating cash flow by Q4 2026.


Key Events · Earnings and Guidance · AMWL

  • Q2 Revenue Decline

    Revenue fell 27% year-over-year to $52.0 million, at the top end of guidance, driven by lower AMG visit revenue and subscription growth.

  • Loss Narrows on Cost Cuts

    Net loss improved to $9.6 million from $10.3 million in Q1 2026, as operating expenses dropped sharply across R&D, sales, and G&A.

  • Full-Year Guidance Raised

    Revenue outlook raised to $200-$205 million (from $195-$205 million) and Adjusted EBITDA improved to ($9)-($7) million (from ($16)-($12) million).

  • Positive Cash Flow Target

    Company reiterated objective to achieve positive cash flow from operations in Q4 2026, supported by $195.9 million in cash reserves.


Analysis · AMWL · Trade & Services

Amwell's Q2 revenue dropped 27% year-over-year to $52 million, but aggressive cost-cutting narrowed the net loss to $9.6 million and turned operating cash flow positive. The company raised the low end of its full-year revenue guidance and significantly improved its Adjusted EBITDA outlook, projecting positive cash flow from operations by Q4 2026. The DHA's intent to make Amwell a prime contractor adds a potential growth catalyst. While the top-line decline is concerning, the improved profitability trajectory and cash position extending the runway are positive signals for a company that recently replaced its auditor and saw a co-founder resign.

How filings like this one have moved

In the 30 days to Nov 4, 2026, 32.4% of the 2240 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AMWL was trading at $11.75 on NYSE in the Trade & Services sector, with a market capitalization of approximately $174.1M. The 52-week trading range was $3.71 to $13.45. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AMWL - Latest Insights

AMWL
Nov 03, 2026, 4:14 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $13.00
Real-time Price: $12.70 info
Change: -$0.300 (-2%) info
Market Cap: $216.692M info
AMWL
Nov 03, 2026, 4:12 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.40
Real-time Price: $12.70 info
Change: +$0.300 (+2%) info
Market Cap: $216.692M info
AMWL
Nov 03, 2026, 4:06 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $12.40
Real-time Price: $12.70 info
Change: +$0.300 (+2%) info
Market Cap: $216.692M info
AMWL
Sep 08, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $13.22
Real-time Price: $12.70 info
Change: -$0.520 (-4%) info
Market Cap: $216.692M info
AMWL
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $13.04
Real-time Price: $12.70 info
Change: -$0.340 (-3%) info
Market Cap: $216.692M info